Intrexon to purchase 48% of AquaBounty Technologies
In Virginia, Intrexon Corp., a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, announced that it has entered into a definitive purchase agreement to acquire an approximately 48% interest in AquaBounty Technologies from existing shareholders. ABT is a biotechnology company focused on enhancing the productivity in aquaculture. Under the […]














